TNSN00247A1 - Combinaison de trimebutine avec un analgesique opioide . - Google Patents

Combinaison de trimebutine avec un analgesique opioide .

Info

Publication number
TNSN00247A1
TNSN00247A1 TNTNSN00247A TNSN00247A TNSN00247A1 TN SN00247 A1 TNSN00247 A1 TN SN00247A1 TN TNSN00247 A TNTNSN00247 A TN TNSN00247A TN SN00247 A TNSN00247 A TN SN00247A TN SN00247 A1 TNSN00247 A1 TN SN00247A1
Authority
TN
Tunisia
Prior art keywords
trimebutine
combination
opioid analgesic
maleateü
nociception
Prior art date
Application number
TNTNSN00247A
Other languages
English (en)
Inventor
Jacques Hamon
Francois Roman
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of TNSN00247A1 publication Critical patent/TNSN00247A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'INVENTION FOURNIT UNE COMBINAISON DE TRIMEBUTINE [HYDROGENOMALEATE DU 3,4,5-TRIMETHOXYBENZOATE DE 2-DIMETHYLAMINO-2- PHENYLBUTYLE] OU DE SES STEREOISOMERES CORRESPONDANTS AVEC UN ANALGESIQUE OPIOIDE POUR LA PREPARATION D'UN MEDICAMENT POUR PREVENIR ET/ OU TRAITER LA DOULEUR OU LA NOCICEPTION.
TNTNSN00247A 1999-12-23 2000-12-20 Combinaison de trimebutine avec un analgesique opioide . TNSN00247A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99125752A EP1138330A1 (fr) 1999-12-23 1999-12-23 Composition d'une combinaison de trimébutine et d'un opioide analgésique

Publications (1)

Publication Number Publication Date
TNSN00247A1 true TNSN00247A1 (fr) 2002-05-30

Family

ID=8239706

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN00247A TNSN00247A1 (fr) 1999-12-23 2000-12-20 Combinaison de trimebutine avec un analgesique opioide .

Country Status (18)

Country Link
US (1) US20030027835A1 (fr)
EP (2) EP1138330A1 (fr)
JP (1) JP2003518492A (fr)
AT (1) ATE246530T1 (fr)
AU (1) AU3365901A (fr)
BR (1) BR0017035A (fr)
CA (1) CA2394745A1 (fr)
CO (1) CO5251459A1 (fr)
DE (1) DE60004400T2 (fr)
DK (1) DK1244498T3 (fr)
ES (1) ES2202220T3 (fr)
GT (1) GT200000225A (fr)
MX (1) MXPA02006374A (fr)
PE (1) PE20010979A1 (fr)
PT (1) PT1244498E (fr)
SI (1) SI1244498T1 (fr)
TN (1) TNSN00247A1 (fr)
WO (1) WO2001047508A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
MX2007000793A (es) * 2004-07-24 2007-03-21 Esteve Labor Dr Uso de compuestos activos sobre el receptor sigma para el tratamiento de alodinia mecanica.
US7645767B2 (en) 2006-08-31 2010-01-12 Trinity Laboratories, Inc. Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5858146A (ja) * 1981-10-05 1983-04-06 Tanabe Seiyaku Co Ltd 速放性マイクロカプセル
FR2772615B1 (fr) * 1997-12-23 2002-06-14 Lipha Comprime multicouche pour la liberation instantanee puis prolongee de substances actives

Also Published As

Publication number Publication date
ES2202220T3 (es) 2004-04-01
GT200000225A (es) 2002-06-15
JP2003518492A (ja) 2003-06-10
WO2001047508A2 (fr) 2001-07-05
AU3365901A (en) 2001-07-09
EP1244498A2 (fr) 2002-10-02
ATE246530T1 (de) 2003-08-15
PE20010979A1 (es) 2001-09-08
DE60004400T2 (de) 2004-06-09
MXPA02006374A (es) 2002-11-29
PT1244498E (pt) 2003-12-31
EP1244498B1 (fr) 2003-08-06
BR0017035A (pt) 2003-01-07
DK1244498T3 (da) 2003-10-27
CO5251459A1 (es) 2003-02-28
DE60004400D1 (de) 2003-09-11
EP1138330A1 (fr) 2001-10-04
CA2394745A1 (fr) 2001-07-05
US20030027835A1 (en) 2003-02-06
SI1244498T1 (en) 2004-02-29
WO2001047508A3 (fr) 2001-12-13

Similar Documents

Publication Publication Date Title
GB9907461D0 (en) Neurite regeneration
DE69925133D1 (de) Pyrrolobenzodiazepine
BG106586A (en) Pyrazolopyramidines as therapeutic agents
HK1049284A1 (en) Benzimidazole compounds having nociceptin receptoraffinity
DK2322187T3 (da) Anvendelse af uridin i kombination med cholin til behandling af hukommelses-lidelser
MXPA03005706A (es) Barra limpiadora de la piel con altos niveles de emoliente liquido.
ZA200104146B (en) Use of apomorphine in the manufacture of a medicament for the treatment of organic erectile dysfunction in males.
HK1068106A1 (en) Use of sarp-1 for the treatment and/or prevention of scleroderma
WO2001039723A3 (fr) Composes triazospiro presentant une affinite pour le recepteur de la nociceptine
EP1274414A4 (fr) Administration nasale d'agents pour traiter la gastroparesie
BR0012553A (pt) Pastilhas contendo ambroxol
TNSN00247A1 (fr) Combinaison de trimebutine avec un analgesique opioide .
ATE275416T1 (de) Verfahren zur verminderung von krebssymptomen
MY133169A (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
MY128529A (en) Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
AU6846300A (en) Use of cyamemazine for cold turkey benzodiazepine treatment
FR2802101B1 (fr) Association de cymemazine et d'un neuroleptique atypique
BR0016720A (pt) Uso de trimebutina para tratamento de dores
CA2452432A1 (fr) Combinaison d'ingredients actifs de pharmacotherapie contre la dependance a la nicotine
EE200200215A (et) 2-amino-3,4-dihüdrokinasoliinide kasutamine ravimi valmistamiseks, mis on ette nähtud isheemilistest seisunditest tingitud haiguste raviks või ennetamiseks
MXPA03005586A (es) Nuevo uso terapeutico de derivado de tienilciclohexilamina.
SE9803623D0 (sv) New therapeutic application
ECSP003850A (es) Combinacion de trimebutina con un analgesico derivado del opio
BR9714382A (pt) 17alfa-diidroequilina para uso como um antioxidante médico
UA34199A (uk) Спосіб лікування пародонтиту